Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TRIAMTERENE AND HYDROCHLOROTHIAZIDE

HYDROCHLOROTHIAZIDE; TRIAMTERENE

Standard Dose
25MG;50MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TRIAMTERENE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 074259 (ANDA).

Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; TRIAMTERENE Form and strength CAPSULE;ORAL - 25MG;50MG Sponsor ANI PHARMS Submission history Latest submission status date: 2002-07-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRIAMTERENE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 074259 (ANDA). Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; TRIAMTERENE Form and strength CAPSULE;ORAL - 25MG;50MG Sponsor ANI PHARMS Submission history Latest submission status date: 2002-07-29 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.